dacarbazine has been researched along with Adenosarcoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aristei, C; Biondetti, PR; Cananzi, FCM; Casali, P; Ciccarone, F; Colombo, N; Comandone, A; Corvo', R; De Iaco, P; Dei Tos, AP; Donato, V; Ferrandina, G; Fiore, M; Gadducci, A; Gronchi, A; Guerriero, S; Infante, A; Lorusso, D; Odicino, F; Pirronti, T; Quagliuolo, V; Sanfilippo, R; Scambia, G; Testa, AC; Zannoni, GF | 1 |
| Babilonti, L; Bertone, A; Bogliolo, S; Cassani, C; Dominoni, M; Gardella, B; Musacchi, V; Spinillo, A; Zanellini, F | 1 |
2 other study(ies) available for dacarbazine and Adenosarcoma
| Article | Year |
|---|---|
Italian consensus conference on management of uterine sarcomas on behalf of S.I.G.O. (Societa' italiana di Ginecologia E Ostetricia).
Topics: Adenosarcoma; Anthracyclines; Antineoplastic Agents; Chemotherapy, Adjuvant; Consensus; Dacarbazine; Female; Humans; Hysterectomy; Ifosfamide; Italy; Lymph Node Excision; Neoplasm Staging; Radiotherapy, Adjuvant; Sarcoma; Uterine Neoplasms | 2020 |
Role of dacarbazine in the treatment of recurrent mullerian adenosarcoma with sarcomatous overgrowth: Our experience.
Topics: Adenosarcoma; Aged; Antineoplastic Agents, Alkylating; Biopsy; Dacarbazine; Female; Humans; Hysterectomy; Hysteroscopy; Lymph Node Excision; Neoplasm Recurrence, Local; Neoplasm Staging; Ovariectomy; Pelvis; Treatment Outcome; Ultrasonography; Uterine Neoplasms; Uterus | 2016 |